A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations

Clinical trial NCT02950064 · UNKNOWN

Trial details

NCT number: NCT02950064
Sponsor: Placon Therapeutics
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Neoplasms Ovarian Neoplasms Breast Neoplasms Prostatic Neoplasms

Start date: 2016-09-01
Primary completion: 2020-04-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.